Fotemustine

This classification denotes a nitrosourea compound with the molecular formula C9H19ClN3O5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GQ7JL9P5I2, chemically known as phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester but more generally known as fotemustine, which bears US NIH Compound Identifier 104799. European Medicines Agency schedules Fotemustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07809MIG. The term FOTEMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules fotemustine in its Anatomical Therapeutic Chemical (ATC) Classification. FOTEMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, FOTEMUSTINE remains US FDA's Preferred Term for this commodity. Fotemustine bears US NLM identifiers UMLS ID C0060696 and NCI Concept Code C1106. SMILES: CLCCN(N=O)C(=O)NC(P(=O)(OCC)OCC)C.